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OBJECTIVES: Esophageal leiomyoma is the most common benign tumor of the esophagus, and it originates
from mesenchymal tissue. This study analyzed the clinicopathological characteristics of esophageal leiomyoma
and aimed to evaluate the role of endoscopic ultrasonography in the diagnosis and treatment selection for
these lesions.
METHODS: Two hundred and twenty-five patients who had suspected esophageal leiomyomas in endoscopic
ultrasonography were enrolled at the Endoscopy Center of The First Affiliated Hospital, Zhejiang University
from January 1st, 2009 to May 31th, 2015. The main outcomes included the demographic and morphological
characteristics, symptoms, comparisons of diagnosis and treatment methods, adverse events, and prognosis.
RESULTS: One hundred and sixty-seven patients were diagnosed as having an esophageal leiomyoma by patho-
logical examination. The mean patient age was 50.57±9.983 years. In total, 62.9% of the lesions originated
from the muscularis mucosa, and the others originated from the muscularis propria. The median distance to the
incisors was 30±12 cm. The median diameter was 0.72±0.99 cm. As determined by endoscopic ultrasonog-
raphy, most existing leiomyomas were homogeneous, endophytic, and spherical. The leiomyomas from the
muscularis mucosa were smaller than those from the muscularis propria and much closer to the incisors (po0.05).
SMA (smooth muscle antibody) (97.2%) and desmin (94.5%) were positive in the majority of patients. In terms of
treatments, patients preferred endoscopic therapies, which led to less adverse events (e.g., intraoperative bleeding,
local infection, pleural effusion) than surgical operations (po0.05). The superficial leiomyomas presented less
adverse events and better recovery (po0.05) than deep leiomyomas.
CONCLUSION: Endoscopic ultrasonography has demonstrated high accuracy in the diagnosis of esophageal
leiomyomas and provides great support in selecting treatments; however, EUS cannot completely avoid mis-
diagnosis, so combining it with other examinations may be a good strategy to solve this problem.
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’ INTRODUCTION
Esophageal leiomyoma is a common type of esophageal
tumor. Although the morbidity varies across different studies,
it is undoubtedly the most common benign tumor of esophagus,
accounting for approximately 70% of esophageal submucosal
tumors (1-4). It is considered an irreversible lesion, and it origi-
nates from mesenchymal tissue. Most cases occur in adults
aged 20 to 80 years, with the average age range of 40 to 50 years
(1,5,6). The patients often have diverse symptoms, and the
symptoms and their severity level seem to be related to lesion
location and shape (7,8). Because of the development of endo-
scopic technology, many non-symptomatic patients with esopha-
geal leiomyomas are diagnosed during normal physical check-ups.
Esophageal leiomyomas always occur in deep layers of
the esophagus (9). Tissue biopsy by forceps may present
false-negatives. The conventional endoscopy could produce
misdiagnoses because of differences in personal experiences.
Endoscopic ultrasonography (EUS) has the ability to check
lesions as well as the adjacent organs and structures (10). It can
easily evaluate the depth of lesions, growth directions, meta-
stasis and other useful parameters.
There are many therapies that are currently available to
treat with esophageal leiomyomas. Doctors used to perform
a thoracotomy to enucleate the whole lesion (11). By the
1990s, thoracoscopy and laparoscopy were widely applied
in this field (12-14). After that, endoscopy and endoscopic
operation were developed and widely used. Several treat-
ments have been deployed on esophageal leiomyomas and
have achieved good results.DOI: 10.6061/clinics/2017(04)01
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The purpose of this study was to summarize the clinico-
pathological characteristics of esophageal leiomyoma and
to analyze the significance of EUS on the diagnosis and
treatment strategy choice of esophageal leiomyomas.
’ METHODS
Subjects
The patients who were enrolled in this study were those
suspected to have an esophageal leiomyoma at the Endo-
scopy Center of The First Affiliated Hospital, Zhejiang
University from January 1st, 2009 to May 31th, 2015. The
total number was 225. The study protocol was approved
by the Ethics Committee of The First Affiliated Hospital,
Zhejiang University. All patients involved in this study were
informed of the potential hazards and signed written
informed consent statements.
EUS procedures
The EUS device was an ultrasound gastroscope (Olympus,
EUS2000) with a 12 MHz miniprobe (Olympus, UM-2R).
EUS examinations utilized the same preparations as conven-
tional gastroscopy.
The suspected esophageal leiomyoma diagnosis criterion
was a homogeneous and hypoechoic structure with clear
borders in the ultrasound image and a submucosal lesion in
the endoscopic image, with no destruction of the mucosa.
Statistical analysis
The parameters that we recorded included the demo-
graphic information of each patient, morphological charac-
teristics of the lesions by EUS and CT scan, pathological and
immunohistochemical staining features of the specimens,
treatments and follow-up conditions. The immunohistochemical
staining markers mainly consisted of desmin, CD117, SMA,
S100, CD34 and DOG1.
The demographics and clinicopathological parameters
were analyzed statistically by IBM SPSS statistics version
19.0 software. Statistical analyses included the Mann-Whitney
U test and the w2 test. The statistical significance was defined
as po0.05.
Follow-up
This study was a retrospective study. The follow-up methods
included telephone calls and repeated patient visits to the
hospital. The follow-up period was calculated from the date
that the EUS was implemented.
’ RESULTS
Characteristics of study subjects
A total of 225 patients were diagnosed as either having an
esophageal leiomyoma or a suspected leiomyoma under
EUS. Among them, 182 patients gave pathological specimens
from endoscopic treatments, surgery and biopsy. The lesions
of 167 patients were confirmed to be consistent with the pre-
operative diagnosis by pathological examination (91.75%).
Fifteen misdiagnosed lesions were actually a mesenchymoma,
inflammatory mass, schwannoma or esophageal carcinoma.
The esophageal leiomyoma patients included 100 males
(59.9%) and 67 females (40.1%). The mean age of these
patients was 50.57±9.983 years (range: 23-72 years), includ-
ing 51.46±10.434 years for male patients and 49.24±9.339
years for females (Table 1).
The median length of the total hospitalization period was
8±6 d, and the median hospitalization time after treatments
was 4±3 d.
Clinicopathological characteristics of
esophageal leiomyoma
Endoscopic characteristics of EUS. Five cases out of the
167 patients had multiple lesions. Four patients had two
lesions, and the other one had three.
The lesions of 105 patients originated in the muscularis
mucosa (62.9%). Of these, 37.1% infiltrated the muscularis
propria (62/167). Of the lesions that infiltrated the mus-
cularis propria, 14.5% infiltrated the superficial muscularis
propria, and 85.5%, the non-superficial layer.
In terms of anatomic locations, the median distance to
the incisors was 30±12 cm (18-42 cm). The percentages of
lesions located in the upper, middle, and lower segments
of esophagus were 16.8%, 41.3% and 41.9%, respectively.
In regard to lesion size, the median diameter of all
esophageal leiomyomas was 0.72±0.99 cm (0.2-8.5 cm).
The diameter of leiomyomas localized in the muscularis
mucosa and muscularis propria were 0.52±0.34 cm and
2.07±1.22 cm, respectively.
During EUS observation, 86.8% of the leiomyomas were
determined to be homogeneous echo (145/167). The leiomyoma
morphologies included spherical (79.6%), fusiform (9.6%),
polypoidal (0.6%), and even 10.2% irregular types. Ten
patients had lesions that were exophytic type (6.0%).
When comparing the lesions from the muscularis mucosa
and muscularis propria, there were no significant difference
related to gender (p=0.540) or symptoms (p=0.949). More
irregular- and exophytic-type leiomyomas originated in the
muscularis propria than in the muscularis mucosa (po0.05).
More muscularis propria lesions had echoes that were homo-
geneous (po0.05).
Whether EUS could accurately diagnose the esophageal
leiomyoma was relative to many parameters of the lesion,
including shape, growth direction, echo, size, origination and
location (Table 2).
Symptoms. Forty-eight of the 167 patients were diag-
nosed unexpectedly during medical checkups. Among the
119 patients with symptoms, the most common one was
upper abdominal discomfort (40.1%). Approximately 9.0%
of the patients suffered from acid reflux and heartburn
(15/119). Dysphagia also occurred in 9.0% (15/119) of the
Table 1 - Patients’ basic characteristics.
Age (years) [mean±SD (range)] 50.57±9.983 (23-72)
Male (N) 100
Female (N) 67
Length of total hospitalization period (days)
[median±QR]
8±6
Hospitalization time after treatments (days)
[median±QR]
4±3
muscularis mucosa (N) 105
muscularis propria (N) 62
Distance to incisors (cm) [median±QR (range)] 30±12 (18-42)
Location
Upper (N) 28
Middle (N) 69
Lower (N) 70
Diameter [median±QR (range)] 0.72±0.99 (0.2-8.5)
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patients. Other symptoms included thoracalgia (6.6%),
dyspepsia (4.2%), paraesthesia pharynges (1.8%) and nausea
(0.6%).
Neither the demographic nor endoscopic characteristics
of the leiomyoma had an effect on symptom occurrence;
however, specific symptoms, such as dysphagia as a classic
symptom, presented statistical correlation with the distance
between incisors and lesions.
Comparison with CTscan. Among esophageal leiomyoma
patients, 83 patients were given CT scans for assistance.
Twenty-nine patients were reported as having normal eso-
phagi (34.9%). Masses were found in 54 patients, of which
4 patients were diagnosed as having esophageal leiomyomas
(4.8%), and 10 patients had ambiguous outcomes (12.0%).
When compared with the EUS observations, esophageal
leiomyomas from muscularis propria, with large diameters
or inhomogeneous echoes, were easier to detect by CT scan
(Table 3).
Immunohistochemical staining. Only 75 patients agreed
to an immunohistochemical examination but not every patient’s
sample displayed all of the biomarkers. SMA and desmin were
positive in 97.2% and 94.5% of the samples, respectively, and
these were the only markers that were observed in over 90% of
the samples. The specific information is detailed in Table 4.
Treatments. A total of 166 patients were under treat-
ments in our study. Various therapy methods have been used
to treat esophageal leiomyomas. With the exception of the
23 patients who received surgical operations (13.8%), the
majority of the patients preferred endoscopic treatments.
Specifically, most patients chose endoscopic trepanned resec-
tion (ETR) (37.7%). Thirty patients received submucosal tun-
neling endoscopic resection (STER) (18.56%). The numbers of
patients who underwent endoscopic mucosal resection (EMR),
endoscopic submucosal dissection (ESD) and endoscopic
submucosal excavation (ESE) were 28, 11 and 10, respectively.
Electric cauterization was implemented on the remaining one
patient.
The intraoperative complications mainly included per-
foration and intraoperative bleeding (450 ml). Perforation
occurred in 7 patients (4.2%), and intraoperative bleeding,
in 18 patients (10.8%). Among the 143 patients who had
endoscopic operations, only two patients endured intra-
operative bleeding 450 ml. The operation methods had no
effect on the occurrence of perforation (p=1.00). Endoscopic
operations led to less intraoperative bleeding than surgical
operations (po0.05) (Table 5).
In comparing leiomyomas from the muscularis mucosa
and muscularis propria, there were many differences between
these two types of lesions (Table 6). The originating location
might significantly impact the therapy choices and prognosis.
Various treatments were used depending on the different
originating depths. ESD and EMR were often performed on
leiomyomas from the muscularis mucosa. For leiomyomas
from the muscularis propria, the main therapies were surgical
operations and endoscopic therapies, including ESE and STER.
Elderly patients with small, homogeneous, regular type lesions
preferred endoscopic therapies more than surgical operations
(Table 7).
Prognosis. The follow-up methods mainly included
repeated patient visits to the hospital and telephone calls.
Table 3 - EUS characteristics of leiomyomas in comparison with
CT scans.
CT missing CT discovery p value
diameter (cm) 0.56±0.58 1.87±2.29 po0.05
muscularis mucosa (N) 19 20 p=0.01o0.05
muscularis propria (N) 10 34
irregular type (N) 27 39 p=0.03o0.05
other types (N) 2 15
endophytic type (N) 28 45 p=0.16
exophytic type (N) 1 9
Table 4 - Immunohistochemical staining of the leiomyomas.
Positive N Percentage (%)
Desmin 69 73 94.5
CD117 20 74 27.0
SMA 70 72 97.2
S100 1 66 1.5
CD34 27 70 38.6
DOG1 4 43 9.3
Table 2 - EUS characteristics of confirmed and suspected leiomyomas.
EUS confirmed EUS suspected p value
shape (N) irregular type 11 6 po0.05
other types 144 6
growth direction (N) endophytic type 148 9 p=0.02o0.05
exophytic type 7 3
echo (N) homogeneous 143 2 po0.05
heterogeneous 12 10
origination (N) muscularis mucosa 105 0 po0.05
muscularis propria 50 12
distance to incisors (cm) 29±11 39±9 po0.05
lesion diameter (cm) 0.65±0.74 3.40±2.18 po0.05
Table 5 - Intraoperative complications of endoscopic operations.
Complication endoscopic
operation
surgical
operation
P value
perforation (N) Y 6 1 p=1.00
N 137 22
intraoperative
bleeding (N)
Y 2 16 po0.05
N 141 7
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A total of 124 patients had subsequent visits after hospital
discharge. The follow-up rate was 74.7%. Among these
individuals, three had endoscopic ultrasonography, four
had CT scans, and the others chose electronic gastroscopy
for examination. The mean follow-up time was 26.7±17.6
months.
The postoperative adverse events were divided into
short-term and long-term. The short-term postoperative
adverse events that we recorded were delayed bleeding,
local infection, pneumomediastinum, pneumothorax and
pleural effusion. The most common one was pleural effusion,
which happened in 28 patients (16.9%). The 23 patients who
had surgical operations all suffered from pleural effusion.
The incidences of delayed bleeding, local infection, pneu-
momediastinum, and pneumothorax were 1.2%, 5.4%, 3.6%
and 3.0%, respectively. Of 166 patients in our study, 33 had
these events. Local infection and pleural effusion occurred
more commonly after surgical treatments. In terms of short-
term postoperative adverse events, endoscopic treatments might
be more advantageous than surgical methods (Table 8).
The long-term adverse events included recurrence, cicatriza-
tion, esophageal stenosis, diverticulum and residual lesions.
Thirty-six patients formed scar tissue in the esophagus (21.7%).
Three patients had residual lesions. Only one patient developed
esophageal diverticulum. There was no significant difference
between endoscopic and surgical treatments in terms of long-
term adverse effects. Lesions originating from the muscularis
propria exhibited the same long-term effects after ESE or STER
as with surgical treatments.
’ DISCUSSION
With the use of EUS, our study reveals the peak incidence
age of esophageal leiomyoma is approximately 40-60 years.
Male patients are slightly more likely to develop these lesions
than females (1,15). It has been established that 83.2% of
these lesions are located in the middle, lower segment of the
esophagus, and the percentage of symptomatic individuals is
71.3%. Dysphagia occurs more frequently in patients with
lower lesions. Furthermore, none of the symptoms have any
correlation with lesion location. Compared with previous
studies, the percentage of symptomatic individuals is obvi-
ously higher (7,16). This result may be because of an admis-
sion bias, the rising attention to self-health, nerve sensitivity
and mental fluctuation.
In the past, conventional endoscopy and CT scans were
often used to detect esophageal lesions. More than half of the
lesions grow from the muscularis mucosa. Conventional
endoscopy can easily detect superficial lesions, but it cannot
evaluate origination, growth direction and some other
characteristics. In addition, approximately 40% of esophageal
leiomyomas originate from the muscularis propria, which
may increase the difficulty of diagnosis and biopsy. All these
situations make it very hard to differentiate esophageal
leiomyomas from other analogous lesions.
In our research, CT scans are good at discovering large,
irregular leiomyomas with deep origination. Depending on
its sharpness, it may not be easy to clearly identify the nature
of the lesions.
EUS has significant advantages over these two methods.
It can discover lesions, and assess depth, size, shape, and
growth direction. Finally, it can distinguish the nature of
Table 6 - Characteristics of esophageal leiomyomas from the muscularis mucosa and muscularis propria.
muscularis mucosa muscularis propria p value
no symptoms (N) 75 44 p=0.95
age 51.90±9.38 48.31±10.64 p=0.02o0.05
distance to incisors (cm) 27.00±10.00 35.50±11.00 po0.05
lesion diameter (cm) 0.52±0.34 1.87±1.58 po0.05
irregular type (N) 0 17 po0.05
exophytic growth (N) 1 9 po0.05
homogeneous echo (N) 2 20 po0.05
EUS confirmed (N) 105 50 po0.05
intraoperative bleeding450 ml (N) 1 17 po0.05
intraoperative perforation (N) 0 7 po0.05
hospitalization time after treatment (days) 3±2 6±2 po0.05
open diet time (days) 1±1 4±3 po0.05
Table 7 - Characteristics of patients who underwent ESE+STER
and surgical operation.
ESE+STER surgical
operation
p value
male 25 14 p=0.93
female 15 8
age 50.30±10.50 44.68±10.13 p=0.046o0.050
symptom 31 13 p=0.13
no symptom 9 9
EUS confirmed 35 15 p=0.13
EUS suspected 5 7
irregular type 35 10 po0.05
other types 5 12
endophytic growth 37 16 p=0.08
exophytic growth 3 6
homogeneous echo 33 9 po0.050
inhomogeneous echo 7 17
distance to incisors (cm) 36.00±11.00 35.00±11.25 p=0.70
lesion diameter (cm) 1.28±0.96 2.69±1.73 po0.05
Table 8 - Postoperative adverse events of endoscopic and
surgical operation.
postoperative
adverse events
endoscopic
operation
surgical
operation
p value
delayed bleeding (N) Y 1 1 p=0.259
N 142 22
local infection (N) Y 3 6 po0.05
N 140 17
pneumomediastinum (N) Y 6 0 p=0.597
N 137 23
pneumothorax (N) Y 3 2 p=0.142
N 140 21
pleural effusion (N) Y 5 23 po0.05
N 138 0
short-term adverse events Y 10 23 po0.05
N 133 0
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lesions. It can significantly impact the diagnosis and selection
of the treatment strategy. EUS had good sensitivity in our
study. Some esophageal leiomyomas with specific character-
istics are diagnosed more easily, including the endophytic
type, inhomogeneous echo, and superficial origination. Although
this may be related to the doctor’s experience, it also reflects
the endoscopic characteristics. Based on this information, com-
bining conventional endoscopy and CT scan for screening,
followed by EUS could allow for lesions to be observed more
precisely.
Esophageal leiomyomas from the muscularis mucosa
tend to have a better prognosis than the ones from
the muscularis propria. After endoscopic treatment, the
patients with superficial lesions can resume their diets and
leave the hospital earlier. They suffer less postoperation
adverse events. The possible reasons for this difference
may include smaller sizes, more regular shapes, and growth
toward the lumen.
Currently, most patients choose endoscopic therapy to
treat superficial esophageal leiomyomas. When compared
with surgical operation, it reduces the chance of intraopera-
tive hemorrhage and short-term adverse events after treat-
ments. It appears to be much safer. In terms of leiomyomas
from the muscularis propria, there are also some good
endoscopic methods that can be used, such as ESE and STER
(17). They can achieve similar curative effects and prognosis
as surgical treatments. EUS is not only good for diagnosing
esophageal leiomyoma but also for contributing to treatment
strategy choice.
On the other hand, EUS cannot completely avoid mis-
diagnoses, especially for some tumors in mesenchymal tissue.
In our study, misdiagnosed lesions may contain mesenchymo-
mas and schwannomas. Combining EUS with other examina-
tions may be a good method to solve this problem. It will be a
effective way, if the diagnoses combined with histopathology.
These three lesions share some commonalities when observed
during EUS and have similarities in microscopic morphology.
The definite diagnosis is assisted by immunohistochemical stain-
ing. Leiomyomas are usually positive for desmin, SMA, CD117,
CD34 and DOG-1 at low levels. Schwannomas have typical S100
positivity. Mesenchymomas are positive for CD117, CD34 and
DOG-1 at a high level. Several types of biopsies can be imple-
mented by EUS. Microscopic examinations and immunohisto-
chemical staining have the ability to distinguish the nature of
lesions.
In conclusion, our research reveals the recent clinicopatho-
logic developments of esophageal leiomyoma. EUS exhibits
high accuracy in esophageal leiomyoma diagnosis and
provides great support in selecting treatments.
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